The landscape of dementia analysis has progressed dramatically with the advent of advanced biomarkers, such as amyloid PET scans, tau imaging, and blood-primarily based tests that may detect Alzheimer's pathology many years before indications arise. When these technological advancements depict impressive progress in knowing neurodegenerative ailments, they have not diminished https://testing-for-dementia-near44322.livebloggs.com/44693171/the-enduring-price-of-cognitive-evaluation-for-older-older-people